Recipe for cell reprogramming adds protein

August 07, 2008

A drug-like molecule called Wnt can be substituted for the cancer gene c-Myc, one of four genes added to adult cells to reprogram them to an embryonic-stem-cell-like state, according to Whitehead researchers. Researchers hope that such embryonic stem-cell-like cells, known as induced pluripotent (IPS) cells, eventually may treat diseases such as Parkinson's disease and diabetes.

Demonstrated in mice, the elimination of c-Myc represents an important step in creating IPS cells in a manner that in the future may be applied to human therapeutics.

"This is a good sign for the possible replacement of the other three genes used to reprogram cells," says Ruth Foreman, a MD/PhD student in the lab of Whitehead Member Rudolf Jaenisch and a lead co-author on the paper, published online in Cell Stem Cell on August 6. The other lead co-authors are Alex Marson, an MD/PhD student in the labs of Jaenisch and Whitehead Member Richard Young, and Brett Chevalier, a research scientist in the Young lab.

"IPS cells hold great potential for future medicine, but we must learn how to generate these cells in a manner that is safe for clinical therapies," says Young, who is also a professor of biology at Massachusetts Institute of Technology. "This advance in reprogramming is one key step toward that goal,"

Currently, IPS cells can be created by reprogramming adult cells through the use of viruses to transfer four genes (Oct4, Sox2, c-Myc and Klf4) into the cells' DNA. The activated genes then override the adult state and convert the cells to embryonic-like IPS cells.

However, this method poses significant risks for potential use in humans.

First, the viruses employed in the process, called retroviruses, are associated with cancer because they insert DNA anywhere in a cell's genome, thereby potentially triggering the expression of cancer-causing genes, or oncogenes. Second, c-Myc is a known oncogene whose overexpression can also cause cancer. For IPS cells to be employed to treat human diseases such as Parkinson's, researchers must find safe alternatives to reprogramming with retroviruses and oncogenes.

Earlier research has shown that c-Myc is not strictly required for the generation of IPS cells. However, its absence makes the reprogramming process time-consuming and highly inefficient.

To bypass these obstacles, the Whitehead researchers replaced c-Myc and its retrovirus with a naturally occurring signaling molecule called Wnt3a. When added to the fluid surrounding the cells being reprogrammed, Wnt3a promotes the conversion of adult cells into IPS cells.

"We're not sure if the Wnt molecule is doing the same thing as c-Myc or complementing c-Myc's activity," says Chevalier. "But it does increase stem cell growth similar to c-Myc."

"This is a good start toward using external cues instead of genetic manipulation to reprogram cells," says Marson. "But we still need to eliminate the need for retroviruses for the three other genes."

Although the technique is promising in mouse cells, its potential applications in humans have not been studied, emphasizes Jaenisch, who is also a professor of biology at MIT. "Is the same pathway acting in the human system and can Wnt molecules be used to reprogram human cells?" he asks. "We don't know, but I think those are very important questions to investigate."

Whitehead Institute for Biomedical Research

Cell and Molecular Biology (Lippincott's Illustrated Reviews Series)
by Nalini Chandar (Author), Susan Viselli PhD (Author)

Lippincott's Illustrated Reviews: Cell and Molecular Biology offers a highly visual presentation of essential cell and molecular biology, focusing on topics related to human health and disease. This new addition to the internationally best-selling Lippincott's Illustrated Reviews Series includes all the popular features of the series: an abundance of full-color annotated illustrations, expanded outline format, chapter summaries, review questions, and case studies that link basic science to real-life clinical situations. The book can be used as a review text for a stand-alone cell biology course in medical, health professions, and upper-level undergraduate programs, or in conjunction with Lippincott's Illustrated Reviews: Biochemistry for integrated courses. A companion Website features...

Stem Cells: Scientific Facts and Fiction
by Christine Mummery (Author), Ian Sir Wilmut (Author), Anja Van De Stolpe (Author), Bernard Roelen (Author)

In the past decades our understanding of stem cell biology has increased tremendously. Many types of stem cells have been discovered in tissues of which everyone presumed were unable to regenerate in adults; these include particularly the heart and the brain. There is vast interest in stem cells from biologists and clinicians who see the potential for regenerative medicine and future treatments for chronic diseases like Parkinson, diabetes and spinal cord lesions based on the use of stem cells and entrepreneurs in biotechnology who expect new commercial applications ranging from drug discovery to transplantation therapies. As is often the case in science, many early claims turned out to be different from those expected. Embryonic stem cell therapies have not moved rapidly into clinical...

Induced Pluripotent Stem Cells in Brain Diseases: Understanding the Methods, Epigenetic Basis, and Applications for Regenerative Medicine (SpringerBriefs in Neuroscience)
by Vivi M. Heine (Author), Stephanie Dooves (Author), Dwayne Holmes (Author), Judith Wagner (Author)

Brain diseases can have a large impact on patients and society, and treatment is often not available. A new approach in which somatic cells are reprogrammed into induced pluripotent cells (iPS cells) is a significant breakthrough for regenerative medicine. This promises patient-specific tissue for replacement therapies, as well as disease-specific cells for developmental modeling and drug treatment screening. However, this method faces issues of low reprogramming efficiency, and poorly defined criteria for determining the conversion of one cell type to another. Cells contain epigenetic “memories” of what they were that can affect reprogramming. This book discusses the various methods to reprogram cells, the control and determination of cell identity, the epigenetic models that have...

Primary and Stem Cells: Gene Transfer Technologies and Applications
by Uma Lakshmipathy (Author), Bhaskar Thyagarajan (Author)

This book describes basic cell engineering methods, emphasizing stem cell applications, and use of the genetically modified stem cells in cell therapy and drug discovery. Together, the chapters introduce and offer insights on new techniques for engineering of stem cells and the delivery of transgenes into stem cells via various viral and non-viral systems. The book offers a guide to the types of manipulations currently available to create genetically engineered stem cells that suit any investigator's purpose, whether it's basic science investigation, creation of disease models and screens, or cells for therapeutic applications.

Stem Cells in Reproduction and in the Brain (Ernst Schering Foundation Symposium Proceedings)
by John Morser (Editor), S. -I. Nishikawa (Editor), H.R. Schoeler (Editor)

Expectations of the potential of regenerative medicine have risen recently because of exciting research results. This book contains contributions from leading researchers who describe their successes and the problems that remain in converting the hopes into concrete therapies. The focus of the book is on the role of stem cells in two main areas -- reproduction and the brain -- described from molecular, cellular, in vivo and clinical perspectives.

International Review Of Cytology, Volume 244: A Survey of Cell Biology (International Review of Cell and Molecular Biology)
by Kwang W. Jeon (Editor)

International Review of Cytology presents current advances and comprehensive reviews in cell biology - both plant and animal. Authored by some of the foremost scientists in the field, each volume provides up-to-date information and directions for future research. Articles in this volume address Plastid RNA polymerases, promoters, and transcription regulators in higher plants; Maintenance of Golgi Apparatus Structure in the Face of Continuous Protein Recycling to the ER: Making Ends Meet; Nucleocytoplasmic trafficking in plant cells; Building in vitro models of organs; Mitrochondria-drived organelles in protists and fungi; The flagellum of trypanosomes; and Regulation of growth and differentiation in Dictyostelium.

Cell Fusion in Health and Disease: I: Cell Fusion in Health (Advances in Experimental Medicine and Biology)
by Thomas Dittmar (Editor), Kurt S. Zänker (Editor)

Although cell fusion is an omnipresent process in life, to date considerably less is still known about the mechanisms and the molecules being involved in this biological phenomenon in higher organisms. In Cell Fusion in Health and Disease Vol 1 & Vol 2 leading experts will present up-to-date overviews about cell fusion in physiological and patho-physiological processes, which further covers the current knowledge about cell fusion-mediating molecules. Volume 1 deals with Cell Fusion in Health and will cover aspects of cell fusion in fertilization, placentation, in C. elegans, in skeletal muscle development and tissue repair, and the use of cell fusion for cellular reprogramming and cancer vaccine development. Volume 2 focuses on Cell Fusion in Disease with a particular emphasis on the role...

Cell Fusion in Health and Disease: II: Cell Fusion in Disease (Advances in Experimental Medicine and Biology)
by Thomas Dittmar (Editor), Kurt S. Zänker (Editor)

Although cell fusion is an omnipresent process in life, to date considerably less is still known about the mechanisms and the molecules being involved in this biological phenomenon in higher organisms. In Cell Fusion in Health and Disease Vol 1 & Vol 2 leading experts will present up-to-date overviews about cell fusion in physiological and patho-physiological processes, which further covers the current knowledge about cell fusion-mediating molecules. Volume 1 deals with Cell Fusion in Health and will cover aspects of cell fusion in fertilization, placentation, in C. elegans, in skeletal muscle development and tissue repair, and the use of cell fusion for cellular reprogramming and cancer vaccine development. Volume 2 focuses on Cell Fusion in Disease with a particular emphasis on the role...

Stem Cell and Tissue Engineering
by Song Li (Author), Song Li (Editor), Nicolas L'Heureux (Editor), Jennifer Elisseeff (Editor)

Tissue engineering integrates knowledge and tools from biological sciences and engineering for tissue regeneration. A challenge for tissue engineering is to identify appropriate cell sources. The recent advancement of stem cell biology provides enormous opportunities to engineer stem cells for tissue engineering. The impact of stem cell technology on tissue engineering will be revolutionary. This book covers state-of-the-art knowledge on the potential of stem cells for the regeneration of a wide range of tissues and organs and the technologies for studying and engineering stem cells. It serves as a valuable reference book for researchers and students.

Gene Targeting and Embryonic Stem Cells (Advanced Methods)
by Jim Mcwhir (Author), Alison Thomson (Author)

Gene Targeting and Embryonic Stem Cells is a practical guide designed for the rapidly growing number of researchers who are moving into this field. Provides details on how to culture, transfect and differentiate established cell lines, and how to isolate new cell lines. Gene targeting experiments are described for a number of cell types, including ungulate fetal fibroblasts, murine ES cells, human embryonal carinoma cells and human ES cells, and include protocols for gene-targeting vectors, DNA transfection and RNA interference.